Suppression of Host Nucleotide Synthesis Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Suppression of Host Nucleotide Synthesis Therapy, covering 2022-02-16 to 2022-02-16. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Anti-coronavirus Response of Suppression of Host Nucleotide Synthesis in Patients With COVID-19 [Phase 1, Phase 2]